Position Papers

18 Nov 2012

Position Paper for Rare Diseases and Orphan Drugs Registries and Databases

BACKGROUND AND PURPOSE OF THE POSITION PAPERRegistries are well-established & commonly-used methods for tracking and reporting clinical outcome, safety, effectiveness and epidemiological endpoints for...

Read more
21 May 2012

EBE Position Paper on Tendering of Biologicals, including Biosimilars

The procurement practice is primarily used for medicines which are genuinely identical, bio-equivalent, multi-sourced and off-patent, i.e., small chemical molecules, so-called generics and their origi...

Read more
31 May 2011

EBE Comments on Concept Paper on Biosimilars Containing Biotech-Derived Proteins as Active Substance

31 May 2011

EBE Comments on EMA GL on Immunogenicity Assessment of mAbs

Download document...

Read more
1 2 3 4